North Dakota State Investment Board Takes Position in Tenet Healthcare Corporation $THC

North Dakota State Investment Board acquired a new stake in Tenet Healthcare Corporation (NYSE:THC) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,066 shares of the company’s stock, valued at approximately $609,000.

Several other hedge funds have also modified their holdings of the stock. Elyxium Wealth LLC acquired a new stake in shares of Tenet Healthcare in the fourth quarter valued at $29,000. Leuthold Group LLC raised its stake in shares of Tenet Healthcare by 9.7% in the fourth quarter. Leuthold Group LLC now owns 32,784 shares of the company’s stock valued at $6,515,000 after acquiring an additional 2,912 shares in the last quarter. Beese Fulmer Investment Management Inc. acquired a new stake in shares of Tenet Healthcare in the fourth quarter valued at $215,000. DNB Asset Management AS raised its stake in shares of Tenet Healthcare by 7.7% in the fourth quarter. DNB Asset Management AS now owns 32,580 shares of the company’s stock valued at $6,474,000 after acquiring an additional 2,317 shares in the last quarter. Finally, Pinnacle Associates Ltd. acquired a new stake in Tenet Healthcare in the fourth quarter valued at $314,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider R. Scott Ramsey sold 8,017 shares of Tenet Healthcare stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the sale, the executive vice president owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 46,517 shares of company stock worth $10,943,111. Company insiders own 0.97% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Mizuho raised their price target on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research note on Thursday, March 12th. Barclays cut their price target on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. Guggenheim cut their price target on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Wall Street Zen cut Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Finally, Wells Fargo & Company cut their price target on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Nineteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Stock Performance

NYSE THC opened at $177.96 on Friday. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 52-week low of $146.60 and a 52-week high of $247.21. The business’s 50-day moving average price is $195.29 and its 200 day moving average price is $203.09. The firm has a market cap of $15.33 billion, a P/E ratio of 9.25, a P/E/G ratio of 1.24 and a beta of 1.30.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business’s revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the company posted $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, equities research analysts expect that Tenet Healthcare Corporation will post 17.64 earnings per share for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.